These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32719257)

  • 1. Quality of life of head and neck cancer patients before and after cancer-directed treatment - A longitudinal study.
    Bashir A; Kumar D; Dewan D; Sharma R
    J Cancer Res Ther; 2020; 16(3):500-507. PubMed ID: 32719257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring quality of life among head-and-neck cancer patients in Western India using European organization for research and treatment of cancer questionnaires.
    Parkar S; Sharma A; Shah M
    J Cancer Res Ther; 2022; 18(4):990-996. PubMed ID: 36149151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
    Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
    BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study on the relationships between global health/quality of life and specific head and neck cancer quality of life domains in Puerto Rico.
    Psoter WJ; Aguilar ML; Levy A; Baek LS; Morse DE
    J Prosthodont; 2012 Aug; 21(6):460-71. PubMed ID: 22469330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.
    Bjordal K; Hammerlid E; Ahlner-Elmqvist M; de Graeff A; Boysen M; Evensen JF; Biörklund A; de Leeuw JR; Fayers PM; Jannert M; Westin T; Kaasa S
    J Clin Oncol; 1999 Mar; 17(3):1008-19. PubMed ID: 10071296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
    Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
    Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
    Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quality of life outcome in patients with head and neck squamous cell cancer treated using chemoradiotherapy.
    Tsukada K; Seino Y; Yamashita T
    Auris Nasus Larynx; 2024 Aug; 51(4):674-679. PubMed ID: 38704895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Risk For Depression and Quality of Life in Patients With Head and Neck Cancer.
    Henry M; Chen LM; Ducharme L; Devault-Tousignant C; Rosberger Z; Frenkiel S; Hier M; Zeitouni A; Kost K; Mlynarek A; Richardson K; Chartier G; Mascarella M; Sadeghi N; Sultanem K; Shenouda G; Cury FL; Meaney M
    JAMA Otolaryngol Head Neck Surg; 2024 Jul; 150(7):598-606. PubMed ID: 38814668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year evolution of quality of life following radiotherapy and/or chemotherapy in patients with head and neck cancer.
    Iwanaga K; Ishibashi Y; Maki K; Ura A; Kotake K; Haba K; Sakata T; Nakagawa T; Arima H
    Asia Pac J Oncol Nurs; 2023 Nov; 10(11):100301. PubMed ID: 37885764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based reference values for the European Organization for Research and Treatment of Cancer Head and Neck module.
    Hammerlid E; Adnan A; Silander E
    Head Neck; 2017 Oct; 39(10):2036-2047. PubMed ID: 28708279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Pain Reporting by Head and Neck Cancer Patients at Radiation Oncology Consultation: A Quality-of-Life Analysis.
    Havard M; Esslinger H; Mierzwa M; Kharofa J; Takiar V
    Laryngoscope; 2021 Feb; 131(2):326-332. PubMed ID: 32609888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The validity and reliability of the Turkish version of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer.
    Senkal HA; Hayran M; Karakaya E; Yueh B; Weymuller EA; Hoşal AŞ
    Am J Otolaryngol; 2012; 33(4):417-26. PubMed ID: 22137146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, longitudinal quality-of-life study of patients with head and neck cancer: a feasibility study including the EORTC QLQ-C30.
    Hammerlid E; Bjordal K; Ahlner-Elmqvist M; Jannert M; Kaasa S; Sullivan M; Westin T
    Otolaryngol Head Neck Surg; 1997 Jun; 116(6 Pt 1):666-73. PubMed ID: 9215381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Stage Longitudinal Change of Quality of Life from Pre- to 3 Months after Surgical Treatment in Head and Neck Cancer Patients.
    Tashimo Y; Ihara Y; Yuasa K; Nozue S; Saito Y; Katsuta H; Shimane T; Takahashi K
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3129-3136. PubMed ID: 31653164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.
    Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3495-3505. PubMed ID: 31529149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explorative study on quality of life in relation to salivary secretion rate in patients with head and neck cancer treated with radiotherapy.
    Almståhl A; Alstad T; Fagerberg-Mohlin B; Carlén A; Finizia C
    Head Neck; 2016 May; 38(5):782-91. PubMed ID: 25537660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
    Bottomley A; Tridello G; Coens C; Rolland F; Tesselaar ME; Leemans CR; Hupperets P; Licitra L; Vermorken JB; Van Den Weyngaert D; Truc G; Barillot I; Lefebvre JL
    Cancer; 2014 Feb; 120(3):390-8. PubMed ID: 24452673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.